Skip Navigation

A Randomized Phase II Study of ATR Inhibition in Advanced PD-L1-refractory Merkel Cell Carcinoma: The MATRiX Trial

Brief Summary

Type:
Melanoma

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05947500

Study #:
STUDY00161227

Start Date:
Feb 05, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05947500

View Complete Trial Details & Eligibility at ClinicalTrials.gov